NILOTINIB 200 mg (Ninlib) x 30 Capsules

NILOTINIB 200 mg (Ninlib) x 30 Capsules

$200.00 $115.00
Prescription Required

NILOTINIB 200 mg (Ninlib) is a prescription targeted anticancer medicine used to treat adults and children with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML). It belongs to a class of medicines called tyrosine kinase inhibitors (TKIs) and helps slow or stop the growth of leukaemia cells. It should be taken exactly as prescribed under the supervision of an oncologist.

Generic name NILOTINIB
Strength 200 mg
Manufacturer Hetero
Package size 30 Capsules
Used for Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML)
Availability In Stock
Shipping to USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries.
Enquire via WhatsApp

Uses of NILOTINIB 200 mg

  • Treats newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia
  • Treats chronic-phase Ph+ CML
  • Treats accelerated-phase Ph+ CML in certain patients
  • May be used when other CML treatments are unsuitable or have not worked effectively
  • Helps achieve and maintain long-term disease control

Benefits of NILOTINIB

  • Targets abnormal signals involved in the growth of leukaemia cells
  • Helps slow the progression of CML
  • Supports long-term disease management
  • May help patients achieve a major molecular response
  • Provides a convenient oral treatment option

How Does NILOTINIB 200 mg Work?

Nilotinib 200 mg works by blocking BCR-ABL tyrosine kinase, an abnormal protein produced by the Philadelphia chromosome. This protein promotes the uncontrolled growth of leukaemia cells. By inhibiting its activity, nilotinib helps slow or stop the growth and multiplication of abnormal blood cells.

Side Effects

  • Nausea
  • Headache
  • Fatigue
  • Rash
  • Itching
  • Muscle or joint pain
  • Constipation
  • Low blood cell counts

Precautions

  • Use only under the supervision of an oncologist.
  • Take the medicine on an empty stomach as directed by your healthcare provider.
  • Regular blood tests and electrocardiogram monitoring may be required during treatment.
  • Inform your doctor if you have heart disease, liver disease, or an electrolyte imbalance.
  • Tell your healthcare provider about all medicines and supplements you are taking, as nilotinib may cause serious drug interactions.
  • Avoid grapefruit and grapefruit juice during treatment.
  • Inform your doctor if you are pregnant, planning a pregnancy, or breastfeeding, as the medicine may harm an unborn baby.

Author

Reviewed By

Dr. Neeru Mehta

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.

Enquire via WhatsApp